Clinical trial
A Study Using Intravitreal Injections of a Small Interfering RNA in Patients…
NCT00395057 · Allergan, Industry · Terminated
Key facts
| NCT number | NCT00395057 |
|---|---|
| Title | A Study Using Intravitreal Injections of a Small Interfering RNA in Patients With Age-Related Macular Degeneration |
| Lead sponsor | Allergan, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Choroid Neovascularization, Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | AGN 211745, Ranibizumab 500µg |
| Enrollment | 138 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Nov 2, 2006 |
| Last update posted | Sep 7, 2015 |
| Countries | Australia, Philippines, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: